HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy.

Abstract
Hexose-6-phosphate dehydrogenase (H6PD) is the initial component of a pentose phosphate pathway inside the endoplasmic reticulum (ER) that generates NADPH for ER enzymes. In liver H6PD is required for the 11-oxoreductase activity of 11beta-hydroxysteroid dehydrogenase type 1, which converts inactive 11-oxo-glucocorticoids to their active 11-hydroxyl counterparts; consequently, H6PD null mice are relatively insensitive to glucocorticoids, exhibiting fasting hypoglycemia, increased insulin sensitivity despite elevated circulating levels of corticosterone, and increased basal and insulin-stimulated glucose uptake in muscles normally enriched in type II (fast) fibers, which have increased glycogen content. Here, we show that H6PD null mice develop a severe skeletal myopathy characterized by switching of type II to type I (slow) fibers. Running wheel activity and electrically stimulated force generation in isolated skeletal muscle are both markedly reduced. Affected muscles have normal sarcomeric structure at the electron microscopy level but contain large intrafibrillar membranous vacuoles and abnormal triads indicative of defects in structure and function of the sarcoplasmic reticulum (SR). SR proteins involved in calcium metabolism, including the sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA), calreticulin, and calsequestrin, show dysregulated expression. Microarray analysis and real-time PCR demonstrate overexpression of genes encoding proteins in the unfolded protein response pathway. We propose that the absence of H6PD induces a progressive myopathy by altering the SR redox state, thereby impairing protein folding and activating the unfolded protein response pathway. These studies thus define a novel metabolic pathway that links ER stress to skeletal muscle integrity and function.
AuthorsGareth G Lavery, Elizabeth A Walker, Nil Turan, Daniela Rogoff, Jeffery W Ryder, John M Shelton, James A Richardson, Francesco Falciani, Perrin C White, Paul M Stewart, Keith L Parker, Daniel R McMillan
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 283 Issue 13 Pg. 8453-61 (Mar 28 2008) ISSN: 0021-9258 [Print] United States
PMID18222920 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • NADP
  • Glycogen
  • Carbohydrate Dehydrogenases
  • galactose-6-phosphate dehydrogenase
  • Calcineurin
Topics
  • Animals
  • Calcineurin (metabolism)
  • Carbohydrate Dehydrogenases (deficiency, genetics, metabolism)
  • Endoplasmic Reticulum (enzymology)
  • Enzyme Activation
  • Gene Deletion
  • Glycogen (metabolism)
  • Mice
  • Microscopy, Electron
  • Muscular Diseases (enzymology, genetics, pathology)
  • Mutation (genetics)
  • NADP (metabolism)
  • Oligonucleotide Array Sequence Analysis
  • Protein Folding
  • RNA, Messenger (genetics)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: